Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Neoplasia (New York, N.Y.)|March 27, 2015
JAK kinase inhibition abrogates STAT3 activation and head and neck squamous cell carcinoma tumor growthMalabika Sen, Netanya I Pollock, John Black, et al.
Cancer Prevention Research (Philadelphia, Pa.)|June 25, 2016
Prevention of Carcinogen-Induced Oral Cancer by SulforaphaneJulie E Bauman, Yan Zang, Malabika Sen, et al.
BMC Cancer|November 14, 2018
Analysis of oncogenic activities of protein kinase D1 in head and neck squamous cell carcinomaLiyong Zhang, Zhihong Li, Yehai Liu, et al.
Journal of Chemical Biology|July 8, 2017
Mechanism of action of selective inhibitors of IL-6 induced STAT3 pathway in head and neck cancer cell linesMalabika Sen, Paul A Johnston, Netanya I Pollock, et al.
Assay and Drug Development Technologies|August 29, 2015
HCS campaign to identify selective inhibitors of IL-6-induced STAT3 pathway activation in head and neck cancer cell linesPaul A Johnston, Malabika Sen, Yun Hua, et al.
Bioorganic & Medicinal Chemistry Letters|October 8, 2014
2-Guanidinoquinazolines as new inhibitors of the STAT3 pathwayMatthew G LaPorte, Dimas José da Paz Lima, Feng Zhang, et al.
Bioorganic & Medicinal Chemistry Letters|July 7, 2016
Optimization of pyrazole-containing 1,2,4-triazolo-[3,4-b]thiadiazines, a new class of STAT3 pathway inhibitorsMatthew G LaPorte, Zhuzhu Wang, Raffaele Colombo, et al.
Carcinogenesis|September 19, 2009
Guggulsterone enhances head and neck cancer therapies via inhibition of signal transducer and activator of transcription-3Rebecca J Leeman-Neill, Sarah E Wheeler, Shivendra V Singh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 3, 2023
Response to Neoadjuvant Targeted Therapy in Operable Head and Neck Cancer Confers Survival BenefitMarco A Mascarella, Tolani F Olonisakin, Purva Rumde, et al.
Pageof 4